Correlation of the controlled attenuation parameter with indices of liver steatosis in overweight or obese individuals: A pilot study

European Journal of Gastroenterology and Hepatology

Volumn 27, Issue 3, 2015, Pages 305-312

  Ferraioli, Giovanna ^a   Tinelli, Carmine ^b   Lissandrin, Raffaella ^a   Zicchetti, Mabel ^a   Faliva, Milena ^a   Perna, Simone ^a   Perani, Guido ^c   Alessandrino, Francesco ^a   Calliada, Fabrizio ^a   Rondanelli, Mariangela ^a   Filice, Carlo ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b Ist Ricovero Cura Carattere Sci P   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

controlled attenuation parameter; correlation studies; dual energy X ray absorptiometry; liver steatosis; magnetic resonance; obesity

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; FAT; GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; ATTENUATION; BODY MASS; CONTROLLED ATTENUATION PARAMETER; DUAL ENERGY X RAY ABSORPTIOMETRY; ELASTOGRAPH; FAT MASS; FATTY LIVER INDEX; FEMALE; HEPATIC STEATOSIS INDEX; HEPATOBILIARY PARAMETERS; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OBESITY; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOLOGICAL PARAMETERS; ULTRASOUND; WAIST CIRCUMFERENCE; X RAY BONE DENSITOMETER; ANTHROPOMETRY; COMPLICATION; CROSS-SECTIONAL STUDY; ECHOGRAPHY; ELASTOGRAPHY; FATTY LIVER; MIDDLE AGED; PATHOPHYSIOLOGY; PHOTON ABSORPTIOMETRY; PROCEDURES;

ABSORPTIOMETRY, PHOTON; ADULT; ANTHROPOMETRY; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; ELASTICITY IMAGING TECHNIQUES; FATTY LIVER; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; PILOT PROJECTS; PROSPECTIVE STUDIES; WAIST CIRCUMFERENCE;

EID: 84922309538     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0000000000000287     Document Type: Article

References (37)

1. Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 2005; 42:44-52.
2. Church TS, Kuk JL, Ross R, Priest EL, Biltoft E, Blair SN. Association of cardiorespiratory fitness, body mass index, and waist circumference to nonalcoholic fatty liver disease. Gastroenterology 2006; 130:2023-2030.
3. Lee JH, Kim D, Kim HJ, Lee CH, Yang JI, Kim W, et al. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis 2010; 42:503-508.
4. Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, Tiribelli C. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 2006; 6:33.
5. Bredella MA, Ghomi RH, Thomas BJ, Torriani M, Brick DJ, Gerweck AV, et al. Comparison of DXA and CT in the assessment of body composition in premenopausal women with obesity and anorexia nervosa. Obesity (Silver Spring) 2010; 18:2227-2233.
6. Lee K, Lee S, Kim YJ, Kim YJ. Waist circumference, dual-energy X-ray absortiometrically measured abdominal adiposity, and computed tomographically derived intra-Abdominal fat area on detecting metabolic risk factors in obese women. Nutrition 2008; 24:625-631.
7. Silver HJ, Niswender KD, Kullberg J, Berglund J, Johansson L, Bruvold M, et al. Comparison of gross body fat-water magnetic resonance imaging at 3 Tesla to dual-energy X-ray absorptiometry in obese women. Obesity (Silver Spring) 2013; 21:765-774.
8. Bahl M, Qayyum A, Westphalen AC, Noworolski SM, Chu PW, Ferrell L, et al. Liver steatosis: investigation of opposed-phase T1-weighted liver MR signal intensity loss and visceral fat measurement as biomarkers. Radiology 2008; 249:160-166.
9. Fischer MA, Nanz D, Reiner CS, Montani M, Breitenstein S, Leschka S, et al. Diagnostic performance and accuracy of 3-D spoiled gradient-dual-echo MRI with water-And fat-signal separation in liver-fat quantification: comparison to liver biopsy. Invest Radiol 2010; 45:465-470.
10. Sasso M, Beaugrand M, de Ledinghen V, Douvin C, Marcellin P, Poupon R, et al. Controlled attenuation parameter (CAP): a novel VCTE guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med Biol 2010; 36:1825-1835.
11. Sasso M, Miette V, Sandrin L, Beaugrand M. The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using Fibroscan. Clin Res Hepatol Gastroenterol 2012; 36:13-20.
12. De Lédinghen V, Vergniol J, Foucher J, Merrouche W, le Bail B. Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography. Liver Int 2012; 32:911-918.
13. Sasso M, Tengher-Barna I, Ziol M, Miette V, Fournier C, Sandrin L, et al. Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan®: validation in chronic hepatitis C. J Viral Hepat 2012; 19:244-253.
14. Myers RP, Pollett A, Kirsch R, Pomier-Layrargues G, Beaton M, Levstik M, et al. Controlled attenuation parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography. Liver Int 2012; 32:902-910.
15. Chon YE, Jung KS, Kim SU, Park JY, Park YN, Kim do Y, et al. Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population. Liver Int 2014; 34:102-109.
16. Kumar M, Rastogi A, Singh T, Behari C, Gupta E, Garg H, et al. Controlled attenuation parameter for non-invasive assessment of hepatic steatosis: does etiology affect performance? J Gastroenterol Hepatol 2013; 28:1194-1201.
17. Ferraioli G, Tinelli C, Lissandrin R, Zicchetti M, Dal Bello B, Filice G, et al. Controlled attenuation parameter for evaluation of liver steatosis in chronic viral hepatitis. World J Gastroenterol 2014; 20:6626-6631.
18. de Lédinghen VD, Vergniol J, Capdepont M, Chermak F, Hiriart JB, Cassinotto C, et al. Controlled Attenuation parameter (CAP) for the diagnosis of steatosis: a prospective study of 5, 323 examinations. J Hepatol 2014; 60:1026-1031.
19. Shi KQ, Tang JZ, Zhu XL, Ying L, Li DW, Gao J, et al. Controlled attenuation parameter for the detection of steatosis severity in chronic liver disease: a meta-Analysis of diagnostic accuracy. J Gastroenterol Hepatol 2014; 29:1149-1158.
20. Kamel EG, McNeill G, Van Wijk MC. Usefulness of anthropometry and DXA in predicting intra-Abdominal fat in obese men and women. Obes Res 2000; 8:36-42.
21. Colton T. Statistics in medicine. Boston, MA: Little, Brown and Company; 1974.
22. Recio E, Cifuentes C, Macias J, Mira JA, Parra-Sánchez M, Rivero-Juárez A, et al. Interobserver concordance in controlled attenuation parameter measurement, a novel tool for the assessment of hepatic steatosis on the basis of transient elastography. Eur J Gastroenterol Hepatol 2013; 25:905-911.
23. Abdennour M, Reggio S, Le Naour G, Liu Y, Poitou C, Aron-Wisnewsky J, et al. Association of adipose tissue and liver fibrosis with tissue stiffness in morbid obesity: links with diabetes and BMI loss after gastric bypass. J Clin Endocrinol Metab 2014; 99:898-907.
24. Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease. Gastroenterology 2002; 122:1649-1657.
25. Solga SF, Clark JM, Alkhuraishi AR, Torbenson M, Tabesh A, Schweitzer M, et al. Race and comorbid factors predict nonalcoholic fatty liver disease histopathology in severely obese patients. Surg Obes Relat Dis 2005; 1:6-11.
26. Micklesfield LK, Evans J, Norris SA, Lambert EV, Jennings C, Joffe Y, et al. Dual-energy X-ray absorptiometry and anthropometric estimates of visceral fat in Black and White South African Women. Obesity (Silver Spring) 2010; 18:619-624.
27. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The diagnosis and management of non-Alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012; 55:2005-2023.
28. Gilsanz V, Chung SA, Kaplowitz N. Differential effect of gender on hepatic fat. Pediatr Radiol 2011; 41:1146-1153.
29. Robertson C, Archibald D, Avenell A, Douglas F, Hoddinott P, van Teijlingen E, et al. Systematic reviews of and integrated report on the quantitative, qualitative and economic evidence base for the management of obesity in men. Health Technol Assess 2014; 18:v-vi. xxiii-xxix, 1-424.
30. Cicero AF, DAddato S, Reggi A, Marchesini G, Borghi C. Brisighella Heart Study. Gender difference in hepatic steatosis index and lipid accumulation product ability to predict incident metabolic syndrome in the historical cohort of the Brisighella Heart Study. Metab Syndr Relat Disord 2013; 11:412-416.
31. Karlas T, Petroff D, Garnov N, Böhm S, Tenckhoff H, Wittekind C, et al. Non-Invasive Assessment of hepatic steatosis in patients with NAFLD using controlled attenuation parameter and 1H-MR spectroscopy. PLoS One 2014; 9:e91987.
32. Seung Soo L, Youngjoo L, Namkug K, SeongWho K, Jae Ho B, Seong Ho P, et al. Hepatic fat quantification using chemical shift MR imaging and MR spectroscopy in the presence of hepatic iron deposition: validation in phantoms and in patients with chronic liver disease. J Magn Reson Imaging 2011; 33:1390-1398.
33. Wu CH, Ho MC, Jeng YM, Hsu CY, Liang PC, Hu RH, et al. Quantification of hepatic steatosis: a comparison of the accuracy among multiple magnetic resonance techniques. J Gastroenterol Hepatol 2014; 29:807-813.
34. Raptis DA, Fischer MA, Graf R, Nanz D, Weber A, Moritz W, et al. MRI: the new reference standard in quantifying hepatic steatosis? Gut 2012; 61:117-127.
35. Raptis DA, Fischer MA, Graf R, Nanz D, Clavien PA. MRI as the new reference standard in quantifying liver steatosis: the need for international guidelines. Gut 2012; 61:1370-1371.
36. De Ledinghen V, Corpechot C, Vergniol J, Bedossa P, Chazouilleres O, Menu Y, et al. Liver steatosis assessment with CAP at 3.5 MHz using FibroScan M and XL probe. J Hepatol 2014; 60:S350.
37. Kaul S, Rothney MP, Peters DM, Wacker WK, Davis CE, Shapiro MD, et al. Dual-energy X-ray absorptiometry for quantification of visceral fat. Obesity (Silver Spring) 2012; 20:1313-1318.